StockData
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc. (DCOY) stock

DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.98−0.08 (-7.56%)

Close on Nov 13, 2026Market cap $638.94KP/E –Yield –

Decoy Therapeutics cash

Cash and short-term investments held at the end of each period.

Decoy Therapeutics's cash was $8.17M at Sep 30, 2026. For fiscal 2025 it was $10.71M, up 339.9% from the year before. Over ten years it grew -19.3% a year on average. The highest annual figure on record is $91.47M in fiscal 2015.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.71M+339.9%
FY2024Dec 31, 2024$2.43M-58.7%
FY2023Dec 31, 2023$5.90M-51.3%
FY2022Dec 31, 2022$12.11M-58.6%
FY2021Dec 31, 2021$29.21M+162.8%
FY2020Dec 31, 2020$11.12M+197.4%
FY2019Dec 31, 2019$3.74M-39.0%
FY2018Dec 31, 2018$6.13M-58.1%
FY2017Dec 31, 2017$14.65M-76.1%
FY2016Dec 31, 2016$61.20M-33.1%
FY2015Dec 31, 2015$91.47M+170.2%
FY2014Dec 31, 2014$33.85M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$8.17M+69.8%
Q2 FY2026Jun 30, 2026$8.29M+942.8%
Q1 FY2026Mar 31, 2026$7.82M+334.9%
Q4 FY2025Dec 31, 2025$10.71M+339.9%
Q3 FY2025Sep 30, 2025$4.81M+46.5%
Q2 FY2025Jun 30, 2025$794.89K-75.7%
Q1 FY2025Mar 31, 2025$1.80M-58.9%
Q4 FY2024Dec 31, 2024$2.43M-58.7%
Q3 FY2024Sep 30, 2024$3.28M-56.7%
Q2 FY2024Jun 30, 2024$3.27M-71.6%
Q1 FY2024Mar 31, 2024$4.37M-52.8%
Q4 FY2023Dec 31, 2023$5.90M-51.3%
Q3 FY2023Sep 30, 2023$7.58M-54.9%
Q2 FY2023Jun 30, 2023$11.54M-49.0%
Q1 FY2023Mar 31, 2023$9.27M-61.7%
Q4 FY2022Dec 31, 2022$12.11M-58.6%
Q3 FY2022Sep 30, 2022$16.82M-47.3%
Q2 FY2022Jun 30, 2022$22.65M-31.5%
Q1 FY2022Mar 31, 2022$24.19M-33.9%
Q4 FY2021Dec 31, 2021$29.21M+162.8%
Q3 FY2021Sep 30, 2021$31.90M+233.8%
Q2 FY2021Jun 30, 2021$33.08M+358.0%
Q1 FY2021Mar 31, 2021$36.61M+279.5%
Q4 FY2020Dec 31, 2020$11.12M+197.4%
Q3 FY2020Sep 30, 2020$9.56M+139.0%
Q2 FY2020Jun 30, 2020$7.22M+74.5%
Q1 FY2020Mar 31, 2020$9.65M+67.2%
Q4 FY2019Dec 31, 2019$3.74M-39.0%
Q3 FY2019Sep 30, 2019$4.00M-33.9%
Q2 FY2019Jun 30, 2019$4.14M-73.9%
Q1 FY2019Mar 31, 2019$5.77M-75.9%
Q4 FY2018Dec 31, 2018$6.13M-58.1%
Q3 FY2018Sep 30, 2018$6.05M-84.5%
Q2 FY2018Jun 30, 2018$15.88M-66.3%
Q1 FY2018Mar 31, 2018$23.95M-54.7%
Q4 FY2017Dec 31, 2017$14.65M-76.1%
Q3 FY2017Sep 30, 2017$38.93M–
Q2 FY2017Jun 30, 2017$47.12M–
Q1 FY2017Mar 31, 2017$52.81M–
Q4 FY2016Dec 31, 2016$61.20M–

More Decoy Therapeutics figures

See a number that looks wrong?